John Harrison

John Harrison

Principal Consultant at Metis Cognition Ltd, Kilmington, UK, PhD PhD CSci CPsychol AFBPsS

  • SE5 8AF

    United Kingdom

  • 421

Personal profile

Biographical details

Principal Consultant at Metis Cognition Ltd. with nearly two decades' experience of assisting pharmaceutical and biotechnology companies with the selection and successful integration of cognitive testing into their drug development programs. Recent successful projects have included the development of Brintellix with Lundbeck, Souvenaid with Nutricia and Encenicline with EnVivo Pharma. In the past 2 years I have worked with more than 40 organisations engaged in drug development, including 8 of the current 'Fortune' top 10 pharmaceutical companies. I am also an Associate Professor at the Alzheimer Center at the VU Medical Center in Amsterdam. Current activities include

i) the measurement and treatment of cognition in depression,

ii) the potential for blending drug and non-drug interventions in a variety of CNS disorders and iii) the further development of appropriate cognition tools for use in studies of prodromal and early Alzheimer's disease.

Specialties: Cognitive test selection and administration

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

External positions

Principal Consultant at Metis Cognition Ltd, Kilmington, UK, Metis Cognition Ltd, Kilmington, UK

Associate Professor , VUmc


Dive into the research topics where John Harrison is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or